Operating Metrics 營運指標
Eli Lilly and Company (LLY) Operating Metrics 營運指標
Eli Lilly and Company LLY 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-03-31
最新營運指標
- Mounjaro Revenue
- $27,785.0M · 2026-03-31 來源：Eli Lilly and Company、Eli Lilly and Company、Eli Lilly and Company、Eli Lilly and Company
- Zepbound Revenue
- $15,390.5M · 2026-03-31 來源：Eli Lilly and Company、Eli Lilly and Company、Eli Lilly and Company、Eli Lilly and Company
季度趨勢
| 指標 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 | Q2 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Mounjaro Revenue | $8,662.0M | $7,409.0M | $6,515.1M | $5,198.9M | $3,842.0M | $3,530.0M | $3,112.7M | $3,090.8M |
| Zepbound Revenue | $4,160.0M | $4,261.0M | $3,588.1M | $3,381.4M | $2,312.0M | $1,907.0M | $1,257.8M | $1,243.2M |
資料來源
- Lilly reports first-quarter 2026 financial results · Eli Lilly and Company · 2026-04-30
- Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance · Eli Lilly and Company · 2026-02-04
- Lilly reports third-quarter 2025 financial results · Eli Lilly and Company · 2025-10-30
- Lilly reports second-quarter 2025 financial results · Eli Lilly and Company · 2025-08-07